Group One Trading’s Acumen Pharmaceuticals ABOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44K Sell
19,800
-63,600
-76% -$165K ﹤0.01% 5597
2026
Q2
$223K Buy
+83,400
New +$206K ﹤0.01% 4378
2025
Q4
– Sell
-3,900
Closed -$6.67K – 8351
2025
Q3
$6.67K Buy
+3,900
New +$5.4K ﹤0.01% 7732
2025
Q1
– Sell
-4,700
Closed -$8.08K – 7760
2024
Q4
$8.08K Sell
4,700
-16,700
-78% -$40.2K ﹤0.01% 6438
2024
Q3
$53.1K Sell
21,400
-36,000
-63% -$97.7K ﹤0.01% 4624
2024
Q2
$139K Buy
57,400
+4,700
+9% +$15K ﹤0.01% 3693
2024
Q1
$213K Buy
+52,700
New +$199K ﹤0.01% 3511
2023
Q4
– Sell
-8,600
Closed -$35.7K – 7277
2023
Q3
$35.7K Buy
8,600
+4,500
+110% +$27.8K ﹤0.01% 5403
2023
Q2
$19.7K Buy
+4,100
New +$19.6K ﹤0.01% 6003
2023
Q1
– Sell
-4,500
Closed -$24.3K – 7109
2022
Q4
$24.3K Sell
4,500
-11,400
-72% -$76.6K ﹤0.01% 5483
2022
Q3
$159K Buy
+15,900
New +$91.2K ﹤0.01% 4357

Other funds holding ABOS

Group One Trading's ABOS Position: Q3 2026 in Review

Group One Trading held its Acumen Pharmaceuticals (ABOS) position steady in Q3 2026 at 722 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #7397.

Group One Trading first reported a position in ABOS in Q3 2022 and has held it in 16 quarters since. The position peaked at $304K in Q3 2024. 95 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.

  • Group One Trading held 722 shares of Acumen Pharmaceuticals worth $1.6K as of Q3 2026.
  • Group One Trading left its Acumen Pharmaceuticals share count unchanged in Q3 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7397 holding.
  • Group One Trading first reported a position in Acumen Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Group One Trading's Acumen Pharmaceuticals position peaked at $304K in Q3 2024.
  • 95 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.